Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Increasing Caregiver Engagement in Juvenile Drug Courts: Complete Statistical AnalysisIndependent statistical analysis of Increasing Caregiver Engagement in Juvenile Drug Courts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03051997).
- Increasing Contingency Management Success in Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of Increasing Contingency Management Success in Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00273793).
- Increasing COVID-19 Testing in Chicago’s African American Testing Desserts: Complete Statistical AnalysisIndependent statistical analysis of Increasing COVID-19 Testing in Chicago's African American Testing Desserts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05197452).
- Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients: Complete Statistical AnalysisIndependent statistical analysis of Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science Approach: Complete Statistical AnalysisIndependent statistical analysis of Increasing Documentation and Disclosure of Sickle Cell Trait Status: An Implementation Science Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Increasing Influenza and Tdap Vaccination of Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Increasing Influenza and Tdap Vaccination of Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04444518).
- Increasing Optimal Use of HPV Vaccination in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Increasing Optimal Use of HPV Vaccination in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04180462).
- Increasing Patients’ Engagement in Breast Cancer Surgery Decision-Making: Complete Statistical AnalysisIndependent statistical analysis of Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03766009).
- Increasing Physical Activity Among Sedentary Older Adults:What, Where, When, and With Whom: Complete Statistical AnalysisIndependent statistical analysis of Increasing Physical Activity Among Sedentary Older Adults:What, Where, When, and With Whom: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Increasing Teen Access to Sexual and Mental Health Care: Complete Statistical AnalysisIndependent statistical analysis of Increasing Teen Access to Sexual and Mental Health Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05444855).
- Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy: primary endpoint results, effect estimate with confidence interval,…
- Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital: Complete Statistical AnalysisIndependent statistical analysis of Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Incretins in Impaired Fasting Glucose: Complete Statistical AnalysisIndependent statistical analysis of Incretins in Impaired Fasting Glucose: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00364377).
- IND+LRPEPIndependent statistical analysis of Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IndegoIndependent statistical analysis of Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- INDEPENDENTIndependent statistical analysis of INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02022111).
- Independent Predictors of Mortality in Polytrauma Patients: Complete Statistical AnalysisIndependent statistical analysis of Independent Predictors of Mortality in Polytrauma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669577).
- Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer: Complete Statistical AnalysisIndependent statistical analysis of Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03416153).
- Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate: Complete Statistical AnalysisIndependent statistical analysis of Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size…
- Individualized Music Listening in Acute Leukemia Patients With Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Individualized Music Listening in Acute Leukemia Patients With Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06286332).
- Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations: Complete Statistical AnalysisIndependent statistical analysis of Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05319080).
- Individualized Stereotactic Body Radiotherapy of Liver Metastases: Complete Statistical AnalysisIndependent statistical analysis of Individualized Stereotactic Body Radiotherapy of Liver Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01239381).
- Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Individually Tailored Lighting System to Improve Sleep in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Individually Tailored Lighting System to Improve Sleep in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01855126).
- Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab: Complete Statistical AnalysisIndependent statistical analysis of Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01810042).
- Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial: Complete Statistical AnalysisIndependent statistical analysis of Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00033917).
- INDORSEIndependent statistical analysis of The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED): Complete Statistical AnalysisIndependent statistical analysis of Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin: Complete Statistical AnalysisIndependent statistical analysis of Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin: primary endpoint…
- INDUMAIndependent statistical analysis of Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00207142).
- Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis: Complete Statistical AnalysisIndependent statistical analysis of Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- INEXASIndependent statistical analysis of A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory…
- Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury: Complete Statistical AnalysisIndependent statistical analysis of Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165072).
- INFIELDIndependent statistical analysis of Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Infigratinib in Recurrent High-Grade Glioma Patients: Complete Statistical AnalysisIndependent statistical analysis of Infigratinib in Recurrent High-Grade Glioma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04424966).
- Inflammation and Coronary Endothelial Function: Complete Statistical AnalysisIndependent statistical analysis of Inflammation and Coronary Endothelial Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02366091).
- Inflammation and Postoperative Tramadol Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Inflammation and Postoperative Tramadol Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04330157).
- Inflammation and the Heart: Complete Statistical AnalysisIndependent statistical analysis of Inflammation and the Heart: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01589770).
- Inflammation and Vascular Function in Atherosclerosis: Complete Statistical AnalysisIndependent statistical analysis of Inflammation and Vascular Function in Atherosclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00760019).
- Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics: Complete Statistical AnalysisIndependent statistical analysis of Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04090190).
- Inflammation-Induced CNS Glutamate Changes in Depression: Complete Statistical AnalysisIndependent statistical analysis of Inflammation-Induced CNS Glutamate Changes in Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03004443).
- Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Inflammatory Cytokine Quantification in Infants: Complete Statistical AnalysisIndependent statistical analysis of Inflammatory Cytokine Quantification in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01155830).
- Inflammatory Markers in Trauma Patient Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Inflammatory Markers in Trauma Patient Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03671746).
- Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans: Complete Statistical AnalysisIndependent statistical analysis of Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01749826).
- Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis: Complete Statistical AnalysisIndependent statistical analysis of Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease: Complete Statistical AnalysisIndependent statistical analysis of Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Influence of a Monopoly Game on Subtle Behaviors: Complete Statistical AnalysisIndependent statistical analysis of Influence of a Monopoly Game on Subtle Behaviors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470949).